Company Alzinova AB

Equities

ALZ

SE0007413455

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm Other stock markets 08:59:53 03/05/2024 pm IST			5-day change	1st Jan Change
1.262 ^SEK	+12.28%		+9.17%	-58.42%

25/04	Sweden’s Alzinova Says CEO to Step Down by July-end	MT
25/04	Kristina Torfgård Leaves the CEO Position At Alzinova Ab, Effective July 31, 2024	CI

Alzinova AB is a Sweden-based company, which is primarily involved in the biotechnology industry. The Company is engaged in the discovery and development of therapeutics for the treatment of Alzheimerâs disease. The Company focuses on development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody (ALZ-201). Both products are specifically directed towards the form of oligomeric AÎ² that damages brain synapses.

Number of employees: 4

Managers	Title	Age	Since
Kristina Torfgård CEO	Chief Executive Officer	61	16/19/16
Anders Sandberg FOU	Founder	52	17/11/17
Kirsten Harting CTO	Chief Tech/Sci/R&D Officer	-	14/23/14
Sebastian Hansson PRN	Corporate Officer/Principal	-	01/23/01
Stefan Pierrou PRN	Corporate Officer/Principal	59	01/21/01
Margareth Jorvid LAW	General Counsel	63	01/22/01

Members of the board	Title	Age	Since
Anders Waas BRD	Director/Board Member	67	01/18/01
Per-Göran Gillberg BRD	Director/Board Member	68	01/20/01
Julian Aleksov CHM	Chairman	59	01/23/01
Lena Birgitta Degling Wikingsson BRD	Director/Board Member	61	01/20/01
Clas Malmeström BRD	Director/Board Member	59	01/15/01
Karl Blom BRD	Director/Board Member	55	01/21/01
Carol Routledge BRD	Director/Board Member	-	01/18/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	44,531,265	28,168,822 ( 63.26 %)	0	63.26 %

Alzinova AB

Pepparedsleden 1

431 83, Mölndal

+46 7 08 46 79 75

http://www.alzinova.com

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
ALZINOVA AB	-58.42%	4.59M
MODERNA, INC.	+23.03%	48.09B
LONZA GROUP AG	+46.90%	40.62B
IQVIA HOLDINGS INC.	-3.12%	40.43B
CELLTRION, INC.	-6.20%	28.36B
ICON PUBLIC LIMITED COMPANY	+9.16%	24.89B
ALNYLAM PHARMACEUTICALS, INC.	-20.17%	19.01B
MEDPACE HOLDINGS, INC.	+28.78%	12.09B
BIO-TECHNE CORPORATION	+0.64%	11.88B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.93%	11.8B

Other Biotechnology & Medical Research